Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Prospective, Interventional, Randomized, Double-masked With the Use of Ganciclovir Gel 0.3% for Treatment of Conjunctivitis Caused by Adenovirus."

NCT01600365 is registered in ClinicalTrials.gov with Adapt Produtos Oftalmológicos Ltda. as lead sponsor.

NCT NCT01600365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01600365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Prospective, Interventional, Randomized, Double-masked With the Use of Ganciclovir Gel 0.3% for Treatment of Conjunctivitis Caused by Adenovirus."
Lead sponsor
Adapt Produtos Oftalmológicos Ltda.
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2012
Completion date
June 30, 2012
Enrollment
22 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adenovirus., conjunctivitis